Related Experiment Video
Updated: Jun 13, 2025

09:44
Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
10.0K
Understanding α-amanitin hepatotoxicity: Mechanisms from cellular models
Haowei Wang1, Xiaoxing Zhang1, Xiaodong Li1
1Department of Forensic Medicine, School of Forensic Medicine, Kunming Medical University, Kunming, China.
Toxicology
|June 4, 2025
Summary
Alpha-amanitin (α-AMA), a toxic mushroom compound, causes liver damage via multiple cellular pathways. Understanding these mechanisms is key to developing better treatments for α-AMA poisoning.
Area of Science:
- Toxicology
- Hepatology
- Cell Biology
Background:
- Alpha-amanitin (α-AMA) is a lethal toxin found in mushrooms, responsible for severe mushroom intoxication.
- Hepatotoxicity is a major consequence of α-AMA poisoning, driven by complex and multifaceted cellular mechanisms.
Purpose of the Study:
- To synthesize current knowledge on α-AMA-induced hepatotoxicity, focusing on recent cellular model findings.
- To elucidate the intricate cellular pathways through which α-AMA damages liver cells.
Main Methods:
- Review of existing literature on α-AMA toxicity.
- Analysis of recent studies utilizing cellular models to investigate α-AMA's effects on hepatocytes.
Main Results:
- α-AMA induces hepatotoxicity via RNA polymerase II inhibition, oxidative stress, apoptosis, autophagy, inflammation, and immunotoxicity.
- Emerging evidence implicates endoplasmic reticulum stress and N-glycosylation pathways in α-AMA-mediated liver injury.
Conclusions:
- Current detoxification agents for α-AMA poisoning have suboptimal efficacy.
- Further research into α-AMA's cellular mechanisms is crucial for developing improved therapeutic strategies.
- High-throughput screening and gene-editing technologies may identify novel therapeutic targets for α-AMA toxicity.
Related Concept Videos
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
34
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
34
Anticholinesterase Agents: Poisoning and Treatment
811
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
811

